ResMed Keeps Investors Comfortable with Profits
April 14, 2023
Trending News ☀️
RESMED ($NYSE:RMD): Investors can rest easy knowing that ResMed Inc. is providing them with a good night’s sleep. ResMed Inc. (RMD) is a medical device company that is dedicated to developing innovative solutions to improve the lives of those who suffer from sleep apnea, chronic obstructive pulmonary disease (COPD), and other cardiovascular and respiratory conditions. ResMed’s products and services are sold through direct sales, distributors, and international subsidiaries. ResMed’s stock performance has been strong, with the company reporting strong financial results over the past several years. ResMed’s revenue has grown steadily, thanks to its innovative products, such as the AirMini portable CPAP, and its focus on providing high-quality service and customer care.
The company also recently announced a $2 billion share repurchase program to further reward shareholders. Overall, ResMed’s commitment to providing quality products and service has kept investors comfortable with their investments in the company. With its strong financials, innovative product lineup, and focus on customer care, ResMed is well-positioned to continue delivering strong returns for its investors in the future.
Share Price
On Thursday, RESMED INC stock opened at $224.1 and closed at $226.6, up 2.0% from the previous closing price of $222.2. The company has grown its positive performance with a string of profitable quarters, which has encouraged investors to stay put in their investments. Furthermore, the company’s innovative products have propelled its growth, as it continues to invest in new technologies and expand its presence in overseas markets. All these efforts have enabled RESMED INC to keep investors comfortable with profits. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Resmed Inc. More…
| Total Revenues | Net Income | Net Margin |
| 3.76k | 809.47 | 21.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Resmed Inc. More…
| Operations | Investing | Financing |
| 370.22 | -1.19k | 887.66 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Resmed Inc. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 6.68k | 2.94k | 25.45 |
Key Ratios Snapshot
Some of the financial key ratios for Resmed Inc are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 10.6% | 14.8% | 28.0% |
| FCF Margin | ROE | ROA |
| 5.9% | 18.4% | 9.9% |
Analysis
At GoodWhale, we conducted a fundamental analysis of RESMED INC and our Star Chart has shown that the company has a high health score of 9/10 when it comes to cashflows and debt. This means that RESMED INC is capable of safely riding out any crisis without the risk of bankruptcy. Additionally, it was strong in dividend, growth, and profitability fundamentals while being medium in asset fundamentals. Based on this evaluation, we classified RESMED INC as a ‘gorilla’ – a type of company we consider to have achieved stable and high revenue or earning growth due to its strong competitive advantage. We believe such a company would be attractive to investors looking for consistent returns with less risk associated. More…
Peers
ResMed’s competitors include Natus Medical Inc, Sanara MedTech Inc, and Avita Corp.
– Natus Medical Inc ($NASDAQ:SMTI)
As of 2022, Sanara MedTech Inc has a market cap of 227.36M and a Return on Equity of -22.91%. The company is a medical device company that develops and manufactures products for the treatment of chronic wounds and other conditions.
– Sanara MedTech Inc ($TPEX:4735)
Avita Corp is a biotechnology company that develops, manufactures, and markets products based on regenerative medicine. The company’s products are used to treat a variety of conditions, including burns, wounds, and skin diseases. Avita’s products are sold in over 30 countries worldwide. The company has a market cap of 1.21B as of 2022 and a return on equity of 9.62%.
Summary
RESMED Inc. has provided a good return on investment for shareholders over the past few years. The company has seen strong revenue growth and profitability in its recent quarters, driven by strong demand from new customers across all markets. Its cash flow has been steady, and its balance sheet is healthy, with a low debt-to-equity ratio.
Analysts expect the company to continue to perform well in the future as it continues to invest in new products, research and development, and marketing activities. It is an attractive investment for those looking for long-term growth and stability.
Related Posts
Recent Posts
